Patents by Inventor Doug Mack

Doug Mack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Through Casing Coring
    Publication number: 20140360784
    Abstract: Devices and methods for obtaining core samples from a formation that surrounds a cased wellbore. A coring tool includes a casing cutter for cutting an opening in the casing and a coring device for obtaining a core sample from the formation.
    Type: Application
    Filed: June 10, 2013
    Publication date: December 11, 2014
    Inventors: James C. Hunziker, James Cernosek, Marcelo F. Civarolo, Doug Mack
  • Antimicrobial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components
    Publication number: 20050142113
    Abstract: This invention relates uses of components of plant-like metabolic pathways not including psbA or PPi phosphofructokinase and not generally operative in animals or encoded by the plastid DNA, to develop compositions that interfere with Apicomplexan growth and survival. Components of the pathways include enzymes, transit peptides and nucleotide sequences encoding the enzymes and peptides, or promoters of these nucleotide sequences to which antibodies, antisense molecules and other inhibitors are directed. Diagnostic and therapeutic reagents and vaccines are developed based on the components and their inhibitors.
    Type: Application
    Filed: April 14, 2004
    Publication date: June 30, 2005
    Inventors: Rima McLeod, Craig Roberts, Fiona Roberts, Jennifer Johnson, Michael Kirisits, David Ferguson, Russell Lyons, Ernest Mui, Doug Mack, Benjamin Samuel, Piotr Gornicki, Ellen Zuther
  • Antimicrobial agents, diagnostic reagents, and vaccines based on unique Apicomplexan parasite components
    Patent number: 6737237
    Abstract: This invention relates uses of Toxoplasma gondii chorismate synthase, a component components of plant-like metabolic pathways not including psbA or PPi phosphofructokinase and not generally operative in animals or encoded by the plastid DNA, in assays to develop compositions that interfere with Apicomplexan growth and survival. Components of the pathways include enzymes, transit peptides and nucleotide sequences encoding the enzymes and peptides, or promoters of these nucleotide sequences to which antibodies, antisense molecules and other inhibitors are directed. Diagnostic and therapeutic reagents and vaccines are developed based on T. gondii chorismate synthase and its inhibitors.
    Type: Grant
    Filed: August 3, 2000
    Date of Patent: May 18, 2004
    Assignee: Apicomplexan Therapeutics, LLC
    Inventors: Rima L. McLeod, Craig W. Roberts, Fiona Roberts, Jennifer J. Johnson, Michael Kirisits, David Ferguson, Russell Lyons, Ernest Mui, Doug Mack, Benjamin Samuel, Piotr Gornicki, Ellen Zuther
  • Apicomplexan chorismate synthase sequences and an inhibitor of the shikimate pathway
    Publication number: 20030186352
    Abstract: This invention relates uses of components of plant-like metabolic pathways not including psbA or PPi phosphofructokinase and not generally operative in animals or encoded by the plastid DNA, to develop compositions that interfere with Apicomplexan growth and survival. Components of the pathways include enzymes, transit peptides and nucleotide sequences encoding the enzymes and peptides, or promoters of these nucleotide sequences to which antibodies, antisense molecules and other inhibitors are directed. Diagnostic and therapeutic reagents and vaccines are developed based on the components and their inhibitors.
    Type: Application
    Filed: October 10, 2002
    Publication date: October 2, 2003
    Inventors: Rima L. McLeod, Michael Kirisits, Craig W. Roberts, Doug Mack, Ernest Mui, John Barnwell, John Dame, Jane Carlton, Paul Bartlett, Suzanna Parle